AiMediq

AiMediq is a MedTech company developing breathing therapies based on controlled intermittent hypoxia/hyperoxia. Our innovative ReOxy® solution is provided in healthcare facilities, including hospitals and cardiac rehabilitation centers. It is specifically intended for use in cardiac rehabilitation under professional supervision in clinical settings. ReOxy® solution encompasses: - ReOxy® Therapy – Our patented therapeutic procedure that optimizes the beneficial effects of controlled short-term hypoxic exposure. It involves administering individually tailored levels of reduced-oxygen gas mixtures to patients, thereby triggering molecular mechanisms that protect cells in response to variations in oxygen levels. - ReOxy® Medical device – Exclusively built to deliver hypoxic therapy safely and effectively, ReOxy® stands as the unique certified medical device of its kind, ensuring the highest standards of patient care. - ReOxy® Smart Algorithm – A specialized algorithm that customizes therapy for each patient, enhancing precision and personalization in their treatment. AiMediq is also committed to developing new solutions based on intermittent hypoxia to address a range of medical and non-medical needs, including pulmonary rehabilitation, long COVID-19, neuro-rehabilitation, well-being, sports performance, and longevity. For inquiries and further information, please reach out to us at [email protected]

• Employees 4
• Founded 2010